POLDIP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.054600E-01
Normal-vs-Stage2
1.819590E-01
Normal-vs-Stage3
8.981700E-02
Normal-vs-Stage4
6.020200E-01
Stage1-vs-Stage2
4.157000E-01
Stage1-vs-Stage3
9.607700E-02
Stage1-vs-Stage4
8.674400E-01
Stage2-vs-Stage3
2.489400E-01
Stage2-vs-Stage4
8.648800E-01
Stage3-vs-Stage4
4.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.124800E-01
Normal-vs-AfricanAmerican
6.310400E-01
Normal-vs-Asian
1.166980E-01
Caucasian-vs-AfricanAmerican
2.472600E-01
Caucasian-vs-Asian
2.503400E-01
AfricanAmerican-vs-Asian
1.060570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.150000E-01
Normal-vs-Female
2.179200E-01
Male-vs-Female
9.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.192200E-01
Normal-vs-Age(41-60Yrs)
3.837000E-01
Normal-vs-Age(61-80Yrs)
1.883400E-01
Normal-vs-Age(81-100Yrs)
1.842360E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.756200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.736000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.518800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.388300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.642000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.487700E-02
Normal-vs-Daily Drinker
7.174200E-02
Normal-vs-Weekly Drinker
1.187420E-01
Normal-vs-Occasional Drinker
6.275400E-01
Normal-vs-Social Drinker
1.182040E-01
Non Drinker-vs-Daily Drinker
7.961000E-01
Non Drinker-vs-Weekly Drinker
7.353200E-01
Non Drinker-vs-Occasional Drinker
3.074100E-02
Non Drinker-vs-Social Drinker
3.830400E-01
Daily Drinker-vs-Weekly Drinker
5.896400E-01
Daily Drinker-vs-Occasional Drinker
2.729800E-02
Daily Drinker-vs-Social Drinker
2.844600E-01
Weekly Drinker-vs-Occasional Drinker
1.245830E-01
Weekly Drinker-vs-Social Drinker
6.370000E-01
Occasional Drinker-vs-Social Drinker
2.110800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.943400E-01
Normal-vs-Grade 2
8.185600E-01
Normal-vs-Grade 3
8.020600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.057200E-01
Grade 1-vs-Grade 3
8.937200E-01
Grade 1-vs-Grade 4
4.943400E-01
Grade 2-vs-Grade 3
7.021200E-01
Grade 2-vs-Grade 4
8.185600E-01
Grade 3-vs-Grade 4
8.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.248300E-02
Normal-vs-NonDiabetic
2.263400E-01
Diabetic-vs-NonDiabetic
1.226210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.925770E-01
Normal-vs-NoPancreatitis
1.909620E-01
Pancreatitis-vs-NoPancreatitis
8.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.835000E-01
Normal-vs-N1
2.121600E-01
N0-vs-N1
9.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.939800E-01
Normal-vs-TP53-NonMutant
4.458400E-01
TP53-Mutant-vs-TP53-NonMutant
3.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
